FDA inspection
Boehringer Ingelheim Pharma GmbH & Co. Kg: FDA inspection ending Sep 19, 2019
FDA inspection 1102691 · Voluntary Action Indicated (VAI) · Biberach An Der Riss
Key facts
| Inspection ID | 1102691 |
|---|---|
| Firm | Boehringer Ingelheim Pharma GmbH & Co. Kg |
| FEI number | 3002806518 |
| Address | Boehringer Ingelheim Pharma Gmbh & Co. Kg, Birkendorfer Str. 65 |
| City | Biberach An Der Riss |
| Country | Germany |
| Fiscal year | 2019 |
| Inspection end date | Sep 19, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data